- Citations, last 5 years
- 20
- Works, last 5 years
- 8
- h-index
- 30
- Scientists listed
- 4
- Grants since 2016
- 15
Grants received
2023–2024 · research · R43
A Novel Small Molecule Therapeutic for Acute Graft Versus Host Disease
Clifford W Mason · Crestone (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
Development of Therapeutic Products for Antibiotic Resistant Bacteria
Urs Ochsner · Crestone (United States) · funded by National Institutes of Health
2020–2025 · contract · N01
Development of Therapeutic Products for Antibiotic Resistant Bacteria
Urs Ochsner · Crestone (United States) · funded by National Institutes of Health
2020–2021 · research · R43
Preclinical Evaluation of CRS3123 for the Treatment of Helicobacter pylori Infections
Urs Arnold Ochsner · Crestone (United States) · funded by National Institutes of Health
2020–2024 · contract · N01
Development of Therapeutic Products for Antibiotic Resistant Bacteria
Urs Ochsner · Crestone (United States) · funded by National Institutes of Health
2020–2025 · contract · N01
Development of Therapeutic Products for Antibiotic Resistant Bacteria
Urs Ochsner · Crestone (United States) · funded by National Institutes of Health
2020–2025 · contract · N01
Development of Therapeutic Products for Antibiotic Resistant Bacteria
Urs Arnold Ochsner · Crestone (United States) · funded by National Institutes of Health
2019–2020 · contract · N01
Advanced Development of Medical Countermeasures for Infectious Diseases
Urs Ochsner · Crestone (United States) · funded by National Institutes of Health
2019–2024 · contract · N01
Advanced Development of Therapeutic Products for Antibiotic Resistant Bacteria
Urs Ochsner · Crestone (United States) · funded by National Institutes of Health
2019–2022 · contract · N01
Advanced Development of Therapeutic Products for Antibiotic Resistant Bacteria
Urs Ochsner · Crestone (United States) · funded by National Institutes of Health
2019–2026 · contract · N01
Development of Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and Emerging Infectious Diseases
Urs Oschner · Crestone (United States) · funded by National Institutes of Health
2019–2023 · contract · N01
Advanced Development of Therapeutic Products for Antibiotic Resistant Bacteria
Urs Ochsner · Crestone (United States) · funded by National Institutes of Health
2019–2020 · contract · N01
Advanced Development of Therapeutic Products for Antibiotic Resistant Bacteria
Urs Ochsner · Crestone (United States) · funded by National Institutes of Health
2019–2026 · contract · N01
Development of Therapeutic Products for Antibacterial Resistant Infections
Urs Oschner · Crestone (United States) · funded by National Institutes of Health
2018–2019 · grant · Standard Grant
SBIR Phase I: Enhancing the Performance of Scientific Applications Through Intelligent Advice
Brandon Nesterenko · Crestone (United States) · funded by National Science Foundation
